{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-25-000029","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.245832+00:00","generated_at":"2026-05-18T22:14:22.097536+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"iBio updates corporate presentation highlighting obesity and cardiometabolic disease antibodies","bullets":["Filed updated corporate presentation dated June 2025 for investor meetings.","Presentation focuses on breakthrough antibodies for obesity and cardiometabolic diseases.","No financial or pipeline specifics disclosed in the filing or attached exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-25-000029","json":"https://secwatch.observer/filing/0001420720-25-000029.json","markdown":"https://secwatch.observer/filing/0001420720-25-000029.md","text":"https://secwatch.observer/filing/0001420720-25-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072025000029/0001420720-25-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072025000029/ibio-20250624x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:14:22.097536+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}